This is a rare and serious type of cancer that starts in the lining of lymphatic vessels. It's usually found in the arm after surgery for breast cancer. It's considered malignant, meaning it can spread.
Every report comes from a Lived member, sent anonymously.
Have you tried Paclitaxel for Lymphangiosarcoma?
Lymphangiosarcoma is a rare, aggressive cancer that develops in skin and tissue that has been swollen by lymphedema for many years. Lymphedema is long-lasting swelling caused when the lymphatic system, the network of vessels and nodes that drains fluid from tissues, is damaged or does not work properly. The cancer starts in the cells that line small vessels, so doctors today usually classify it as a type of angiosarcoma. When it arises in a swollen limb, it is often called Stewart-Treves syndrome. The classic case is an arm that has been swollen for years after breast cancer surgery that removed lymph nodes from the armpit, often followed by radiation. It can also develop in a leg or other area with long-standing lymphedema from any cause. It matters because it can spread quickly to other parts of the body, and because its early signs are easy to mistake for a bruise or a skin infection.
The main risk factor is chronic lymphedema itself. Researchers think years of trapped fluid, ongoing inflammation and weakened local immune defenses in the swollen tissue create conditions in which vessel-lining cells can become cancerous. In published cases, most people had a history of cancer treatment, especially surgery that removed lymph nodes and radiation therapy. Lymphedema after pelvic surgery, injury, long-term vein problems, infection or a lymphatic condition present from birth has also been linked to it. The cancer usually appears long after the swelling began, typically 5 to 20 years later and on average about 15. Most reported patients are women, with an average age of about 60 at diagnosis, reflecting its link to breast cancer treatment. Having lymphedema does not mean someone will develop this cancer; it remains a rare complication.
Lymphangiosarcoma usually first shows up on the skin of the swollen limb as purple, reddish or bluish patches that look like bruises, raised bumps or nodules, or sores that do not heal. There are often several spots at once. Because these can resemble a bruise, cellulitis (a bacterial skin infection) or other skin conditions, a clinician who sees a new or changing spot in a limb with long-standing lymphedema will often recommend a biopsy rather than waiting. A biopsy, in which a small piece of tissue is removed and examined under a microscope, is the only way to confirm the diagnosis. Special stains show that the tumor cells come from vessel lining and help separate it from look-alikes such as Kaposi sarcoma or breast cancer that has spread to the skin. Imaging such as MRI, CT or PET-CT scans then shows how far the tumor extends in the limb and whether it has spread to the lungs or elsewhere, which guides treatment. Scans alone cannot reliably tell this cancer apart from ordinary lymphedema changes.
Treatment is planned by a team experienced in sarcoma (cancers of connective and soft tissues), because the disease is rare and each case differs. When the cancer is confined to the limb, surgery to remove it with a wide margin of healthy tissue offers the best chance of long-term control. Because the tumor tends to spread through the skin beyond what can be seen, this often means amputating the limb or part of it. That is a major decision, but in published cases, people whose first treatment was surgical removal lived the longest, and some reported better mobility after losing a heavy, swollen limb. Chemotherapy is the main treatment when the cancer cannot be removed or has spread, and it may also be used before or after surgery. Angiosarcomas respond to chemotherapy more often than many sarcomas. Paclitaxel, often given weekly, is the most widely used drug; nerve damage causing numbness or tingling and low blood counts are its main side effects. Doxorubicin is another option, limited by its risk of heart damage with higher total doses. Chemotherapy can shrink or hold the cancer in check for a time, but it is not expected to cure advanced disease. Radiation may modestly improve control in the treated area or ease symptoms, but like chemotherapy it has not been shown to substantially lengthen survival. Immunotherapy drugs that help the immune system attack cancer have shown responses in some angiosarcomas, mostly of the scalp and face, but their role in lymphangiosarcoma is still being studied, often in clinical trials.
Lymphangiosarcoma is a serious cancer with a difficult outlook. In published series, roughly one in five people are alive five years after diagnosis. Results are better when the tumor is found early, is small and can be completely removed, and much worse once it has spread. Individual outcomes vary, and these figures come from small groups of patients collected over many years. After surgery, recovery involves wound healing and, if a limb was amputated, rehabilitation and possibly a prosthesis, along with support for the emotional weight of the change. Chemotherapy is usually given in regular clinic visits over months. Follow-up after treatment includes frequent skin and limb examinations and periodic scans of the chest and body, since the cancer often returns; in a large study of skin angiosarcomas, nearly all recurrences happened within five years. For people living with lymphedema, consistent swelling management (such as compression and lymphatic therapy) and regular skin checks of the affected limb are the main practical steps. They do not guarantee prevention, but they make it more likely that a change will be noticed and investigated early.
If you have long-standing lymphedema, contact your care team promptly about any new purple, red or bluish spot that looks like a bruise but does not fade, a new bump or nodule, or a sore that does not heal on the swollen limb, and ask whether a biopsy is needed. Also go back to the care team if what was treated as a skin infection or bruise does not improve as expected. If you are being treated for lymphangiosarcoma, report new spots, lumps or swelling, new symptoms elsewhere in the body, or troublesome side effects of treatment to your oncology team.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Lymphangiosarcoma is like, what's helped you, or ask the community a question.